Preference for twice-yearly injections vs daily oral pills for HIV PrEP in cisgender men, transgender women, transgender men, and gender nonbinary people enrolled in PURPOSE 2

Conference Reports for NATAP

IAS 2025, 13th IAS Conference on HIV Science
Kigali, Rwanda
July 13-17


Preference for twice-yearly injections vs daily oral pills for HIV PrEP in cisgender men, transgender women, transgender men, and gender nonbinary people enrolled in PURPOSE 2

	IAS 2025 July 13-17 Rwanda ( K. MNGADI )